Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.66 |
| ▸ | RAB9A | P51151 | 3/20 | 0.66 |
| ▸ | AKT1 | P31749 | 1/20 | 0.65 |
| ▸ | AKT2 | P31751 | 1/20 | 0.65 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.55 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | USP7 | Q93009 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953862 | 0.96 | AKT1 (0.66) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL13599904 | 0.96 | AKT1 (0.66) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL24479406 | 0.93 | AKT1 (0.63) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL25789353 | 0.93 | AKT1 (0.63) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL15382793 | 0.93 | AKT1 (0.63) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL22673418 | 0.93 | AKT1 (0.63) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL13131134 | 0.93 | AKT1 (0.58) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL24479218 | 0.92 | AKT1 (0.61) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL22673697 | 0.92 | AKT1 (0.61) | NPC1RAB9AAKT1AKT2ADRA1B | |
| SCHEMBL24479413 | 0.92 | AKT1 (0.61) | NPC1RAB9AAKT1AKT2ADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292595-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230292595-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230270004-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-08-24 | — | — | US | disclosed |
| US-20230270004-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-08-24 | — | — | US | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| EP-4198103-A1 | ORGANIC LIGHT EMITTING DIODE AND DEVICE COMPRISING THE SAME | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-4141979-A1 | ORGANIC LIGHT EMITTING DIODE AND A COMPOUND FOR USE THEREIN | Novaled GmbH (DE) | 2023-03-01 | — | — | EP | disclosed |
| EP-4141980-A1 | ORGANIC LIGHT EMITTING DIODE AND A COMPOUND FOR USE THEREIN | Novaled GmbH (DE) | 2023-03-01 | — | — | EP | disclosed |
| WO-2021250279-A1 | ORGANIC LIGHT EMITTING DIODE AND DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2021-12-16 | — | — | WO | disclosed |
| US-9926316-B2 | Antitumor derivatives for differentiation therapy | THE CLEVELAND CLINIC FOUNDATION (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170253589-A1 | ANTITUMOR DERIVATIVES FOR DIFFERENTIATION THERAPY | THE CLEVELAND CLINIC FOUNDATION | 2017-09-07 | — | — | US | disclosed |
| US-9012042-B2 | Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-04-21 | — | — | US | disclosed |
| US-20120286246-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-11-15 | — | — | US | disclosed |
| US-7714319-B2 | Organic thin film transistor | IDEMITSU KOSAN CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7632578-B2 | Emitting compound for organic electroluminescent device and organic electroluminescent device using the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-12-15 | — | — | US | disclosed |
| US-7632578-B2 | Emitting compound for organic electroluminescent device and organic electroluminescent device using the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-12-15 | — | — | US | disclosed |
| WO-2007129169-A2 | COX- II INHIBITORS FOR IMPROVING REPRODUCTIVE SUCCESS IN A FEMALE ANIMAL | PFIZER LIMITED (GB) | 2007-11-15 | — | — | WO | disclosed |
| US-20070120111-A1 | Organic thin film transistor | IDEMITSU KOSAN CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| US-4186205-A | ANTIARTHRITIC AGENTS | SMITHKLINE CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120286246-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS | OR10J3, AR, ARL1 | NPC1 2555/4885RAB9A 1129/4885AKT1 3179/4885 |
| US-20170253589-A1 | ANTITUMOR DERIVATIVES FOR DIFFERENTIATION THERAPY | MYD88, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS | NPC1 3167/4885RAB9A 1723/4885AKT1 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.